NeuroSense Therapeutics
improved disease progression by after months of treatment | NeuroSense Therapeutics
Company
Deck Type
Sector
Industry
Deck date
October 2024
Slide
15 of 27
Similar slides by NeuroSense Therapeutics
See diffirences between slides (animation)
Investor Presentation
October 2024
| NeuroSense Therapeutics
Related slides by other companies
Myovant Sciences
Results
August 2022
majority of women treated with who used at were free at week | Myovant Sciences
Theravance Biopharma
Investor Conference
November 2022
improved composite score over time and maintained effect during in patients with | Theravance Biopharma
Theravance Biopharma
Investor Conference
November 2022
improved score over time and maintained effect during in patients with | Theravance Biopharma
DICE Therapeutics
Results
March 2023
demographics and disease characteristics dice | DICE Therapeutics
Other recent decks by NeuroSense Therapeutics
See all presentations (4 decks)
Investor Presentation
January 2024
Investor Presentation
December 2023
Investor Presentation
June 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2024 Slidebook.io